Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$23,814,273
+$9,775,186 QoQ
Shares Held
2,657,843
+14.2% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,550,967,073 across 528 Biotechnology names. VIR ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in VIR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,814,273 | 2,657,843 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,039,087 | 2,328,207 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,825,926 | 2,246,222 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $11,352,195 | 2,252,420 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $14,871,800 | 2,295,031 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,123,050 | 2,196,601 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,393,916 | 2,188,774 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $19,434,288 | 2,183,628 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $19,745,284 | 1,949,189 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $18,977,143 | 1,886,396 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $16,808,505 | 1,793,864 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $41,474,759 | 1,690,777 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $35,496,476 | 1,525,418 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,111,496 | 1,466,278 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $27,304,895 | 1,416,229 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $35,119,793 | 1,378,869 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $32,031,456 | 1,245,391 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $51,576,303 | 1,231,820 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $52,039,388 | 1,195,758 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $55,191,835 | 1,167,340 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $55,239,425 | 1,077,422 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $25,879,522 | 966,375 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $31,388,262 | 914,310 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $15,954,660 | 389,423 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,984,915 | 116,280 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||